Due to the complicated situation of increased risk of COVID-19 and the declared State of emergency in the Republic of Bulgaria, many additional factors will influence the conduct of clinical trials in sites on the territory of the country - limited access to medical establishments, limited resources etc.
The patients’ safety and health is a main priority and the changes in the conduct of clinical trials must be based on a detailed risk assessment.
Read more: Recommendations to the Sponsors for managing of Clinical Trials during...